National Vision (NASDAQ:EYE) Shares Down 7.2% - Should You Sell?

Key Points

• Shares fell 7.2% to $24.04 on Wednesday (intraday low $24.17) on ~1.00M shares traded, about 21% below average session volume.
• Analysts hold a "Moderate Buy" consensus with an average target of $31.21, and several firms recently raised targets into the $30–$35 range.
• Q results topped estimates—$0.15 EPS vs. $0.06 expected and revenue $503.4M (up 15.1% YoY) with FY2026 guidance of $0.85–1.09, though the stock trades at a high P/E of 65.2 and has a $1.92B market cap.

National Vision Holdings, Inc. (NASDAQ:EYE - Get Free Report)'s share price traded down 7.2% on Wednesday . The company traded as low as $24.17 and last traded at $24.0390. 1,001,844 shares were traded during trading, a decline of 21% from the average session volume of 1,270,281 shares. The stock had previously closed at $25.90.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on EYE shares. Wolfe Research set a $35.00 price target on National Vision in a report on Wednesday, March 4th. National Bank Financial set a $32.00 price objective on National Vision in a research note on Tuesday, December 9th. Morgan Stanley lifted their target price on National Vision from $26.00 to $30.00 and gave the company an "equal weight" rating in a research note on Thursday, January 15th. Guggenheim boosted their target price on shares of National Vision from $32.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, March 5th. Finally, Wells Fargo & Company increased their price target on shares of National Vision from $27.00 to $30.00 and gave the company an "equal weight" rating in a research report on Thursday, March 5th. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $31.21.

National Vision Stock Performance

The business has a 50-day moving average price of $27.16 and a 200-day moving average price of $27.05. The company has a quick ratio of 0.33, a current ratio of 0.55 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 65.20, a P/E/G ratio of 1.90 and a beta of 1.38.

National Vision (NASDAQ:EYE - Get Free Report) last announced its earnings results on Wednesday, March 4th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.09. National Vision had a return on equity of 5.15% and a net margin of 1.49%.The firm had revenue of $503.41 million for the quarter, compared to the consensus estimate of $495.26 million. During the same period in the previous year, the business earned ($0.04) EPS. The firm's revenue for the quarter was up 15.1% on a year-over-year basis. National Vision has set its FY 2026 guidance at 0.850-1.090 EPS. As a group, sell-side analysts forecast that National Vision Holdings, Inc. will post 0.31 earnings per share for the current year.

Insider Activity

In other news, Chairman L Reade Fahs sold 7,601 shares of the company's stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $29.58, for a total transaction of $224,837.58. Following the transaction, the chairman owned 694,880 shares in the company, valued at $20,554,550.40. This represents a 1.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.70% of the stock is currently owned by company insiders.

Institutional Trading of National Vision

Several large investors have recently bought and sold shares of EYE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in National Vision by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company's stock valued at $591,000 after purchasing an additional 1,948 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of National Vision by 6.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company's stock valued at $3,005,000 after buying an additional 13,384 shares during the last quarter. Creative Planning acquired a new position in shares of National Vision in the 2nd quarter valued at $395,000. Legal & General Group Plc increased its position in shares of National Vision by 5.3% in the 2nd quarter. Legal & General Group Plc now owns 217,869 shares of the company's stock valued at $5,013,000 after acquiring an additional 10,949 shares during the period. Finally, Rhumbline Advisers raised its stake in National Vision by 2.5% in the 2nd quarter. Rhumbline Advisers now owns 235,547 shares of the company's stock worth $5,420,000 after acquiring an additional 5,768 shares during the last quarter.

National Vision Company Profile

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America's Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.